Sanja Rogić

Canada's Michael Smith Genome Sciences Centre — Canada

Medicine · Health Sciences

21h-index5.6kcitations56works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(16), Genomics and Rare Diseases(13), RNA and protein synthesis mechanisms(9), Autism Spectrum Disorder Research(8), Genomics and Phylogenetic Studies(7)

Publications56 total

SETD1A variant-associated psychosis: A systematic review of the clinical literature and description of two new cases
UNC Libraries·2026Open Access
A Cell-Based Assay to Categorize Variants of Human Succinate Semialdehyde Dehydrogenase Associated with Autism Spectrum Disorder
2026Open Access
Persistent hindrances to data re-use in single-cell genomics
2025Open Access
Global partnerships in rare disease research
Disease Models & Mechanisms·2025Open Access
Revealing function-altering MECP2 mutations in individuals with autism spectrum disorder using yeast and <i>Drosophila</i>
Genetics·2025· 3 citedOpen Access
Using semantic search to find publicly available gene-expression datasets
2025Open Access
T74. HIGH YIELD OF DEEP PHENOTYPING AND LONG READ WHOLE GENOME SEQUENCING IN TREATMENT-RESISTANT PSYCHOSIS
European Neuropsychopharmacology·2024
Revealing function-altering MECP2 mutations in individuals with autism spectrum disorder using yeast and <i>Drosophila</i>
2024· 1 citedOpen Access
SETD1A variant-associated psychosis: A systematic review of the clinical literature and description of two new cases
Open MIND·2024
SETD1A variant-associated psychosis: A systematic review of the clinical literature and description of two new cases
Progress in Neuro-Psychopharmacology and Biological Psychiatry·2023· 10 citedOpen Access
ASSESSING THE UTILITY OF PHARMACOGENETIC TESTING IN A COHORT WITH TREATMENT-RESISTANT SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER
European Neuropsychopharmacology·2022
ModelMatcher: A scientist‐centric online platform to facilitate collaborations between stakeholders of rare and undiagnosed disease research
Human Mutation·2022· 15 citedOpen Access
3D-QSAR-based pharmacophore determination and design of novel DPP-4 inhibitors
Scripta Medica·2022Open Access
ModelMatcher: A scientist-centric online platform to facilitate collaborations between stakeholders of rare and undiagnosed disease research
2021· 3 citedOpen Access
TU71. SIGNIFICANT INCIDENCE OF RARE CHROMOSOMAL AND GENOMIC SEQUENCE VARIANTS IN HIGHLY TREATMENT-RESISTANT SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER
European Neuropsychopharmacology·2021
Multi-parametric analysis of 57 SYNGAP1 variants reveal impacts on GTPase signaling, localization, and protein stability
The American Journal of Human Genetics·2020· 18 citedOpen Access
Multi-model functionalization of disease-associated PTEN missense mutations identifies multiple molecular mechanisms underlying protein dysfunction
Nature Communications·2020· 62 citedOpen Access
Multi-parametric analysis of 58 SYNGAP1 variants reveal impacts on GTPase signaling, localization and protein stability
2020· 1 citedOpen Access
The Canadian Rare Diseases Models and Mechanisms (RDMM) Network: Connecting Understudied Genes to Model Organisms
The American Journal of Human Genetics·2020· 50 citedOpen Access
VariCarta: A Comprehensive Database of Harmonized Genomic Variants Found in Autism Spectrum Disorder Sequencing Studies
Autism Research·2019· 35 cited
page 1 of 3Next →

Frequent Co-authors

Paul Pavlidis(21), Randy D. Gascoyne(16), Joseph M. Connors(15), Christian Steidl(14), Susana Ben‐Neriah(13), David W. Scott(10), Marco A. Marra(10), Bruce W. Woolcock(8), King Tan(8), Fong Chun Chan(8), Lisa M. Rimsza(7), Barbara Meissner(7), Robert Kridel(7), Adèle Telenius(7), Manuel Belmadani(7), Guillaume Poirier‐Morency(7), Ryan D. Morin(6), Andrew J. Mungall(6), Nathalie A. Johnson(6), Merrill Boyle(6)